209 related articles for article (PubMed ID: 21878358)
21. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
[TBL] [Abstract][Full Text] [Related]
22. Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.
Villanueva-Romero R; Gutiérrez-Cañas I; Carrión M; González-Álvaro I; Rodríguez-Frade JM; Mellado M; Martínez C; Gomariz RP; Juarranz Y
Sci Rep; 2019 May; 9(1):7383. PubMed ID: 31089161
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W
Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947
[TBL] [Abstract][Full Text] [Related]
24. Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide.
Fabricius D; O'Dorisio MS; Blackwell S; Jahrsdörfer B
J Immunol; 2006 Nov; 177(9):5920-7. PubMed ID: 17056516
[TBL] [Abstract][Full Text] [Related]
25. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
Cunha-Reis D; Ribeiro JA; Sebastião AM
Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
[TBL] [Abstract][Full Text] [Related]
26. Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.
Seoane IV; Ortiz AM; Piris L; Lamana A; Juarranz Y; García-Vicuña R; González-Álvaro I; Gomariz RP; Martínez C
PLoS One; 2016; 11(2):e0149141. PubMed ID: 26881970
[TBL] [Abstract][Full Text] [Related]
27. Role of VPAC2 receptor in monocrotaline-induced pulmonary hypertension in rats.
Koga M; Mizuno Y; Watanabe I; Kawakami H; Goto T
J Appl Physiol (1985); 2014 Aug; 117(4):383-91. PubMed ID: 24947028
[TBL] [Abstract][Full Text] [Related]
28. VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.
Storka A; Burian B; Führlinger G; Clive B; Sun T; Crevenna R; Gsur A; Mosgöller W; Wolzt M
J Transl Med; 2013 May; 11():117. PubMed ID: 23651810
[TBL] [Abstract][Full Text] [Related]
29. Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets.
Vuckovic A; Rondelet B; Brion JP; Naeije R
Pediatr Res; 2009 Oct; 66(4):395-9. PubMed ID: 19581838
[TBL] [Abstract][Full Text] [Related]
30. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).
Huang MC; Miller AL; Wang W; Kong Y; Paul S; Goetzl EJ
J Immunol; 2006 Jun; 176(11):6640-6. PubMed ID: 16709822
[TBL] [Abstract][Full Text] [Related]
31. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries.
Grant S; Lutz EM; McPhaden AR; Wadsworth RM
J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.
Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B
J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481
[TBL] [Abstract][Full Text] [Related]
33. Effect of VIP on intracellular [Ca2+], extracellular regulated kinase 1/2, and secretion in cultured rat conjunctival goblet cells.
Li D; Jiao J; Shatos MA; Hodges RR; Dartt DA
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2872-84. PubMed ID: 23518767
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart.
Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ
Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371
[TBL] [Abstract][Full Text] [Related]
35. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.
Burian B; Storka A; Marzluf BA; Yen YC; Lambers C; Robibaro B; Vonbank K; Mosgoeller W; Petkov V
Peptides; 2010 Apr; 31(4):603-8. PubMed ID: 20026142
[TBL] [Abstract][Full Text] [Related]
37. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
[TBL] [Abstract][Full Text] [Related]
38. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.
Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA
Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659
[TBL] [Abstract][Full Text] [Related]
39. Contribution of vasoactive intestinal peptide to immune homeostasis in trophoblast-maternal leukocyte interaction under LPS stimulation.
Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Pérez Leirós C; Ramhorst R
Neuroimmunomodulation; 2014; 21(1):21-30. PubMed ID: 24135863
[TBL] [Abstract][Full Text] [Related]
40. Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice.
Roca V; Calafat M; Larocca L; Ramhorst R; Farina M; Franchi AM; Leirós CP
Reproduction; 2009 Oct; 138(4):733-42. PubMed ID: 19633131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
